The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.

Maha N Syed Daniel B Shin Marilyn T Wan Kevin L Winthrop Joel M Gelfand

J Am Acad Dermatol

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address:

Published: November 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331500	PMC
http://dx.doi.org/10.1016/j.jaad.2020.06.1014	DOI Listing

Publication Analysis

Top Keywords

risk respiratory

respiratory tract

tract infections

infections patients

patients psoriasis

psoriasis treated

treated interleukin

interleukin pathway-inhibiting

pathway-inhibiting biologics

biologics meta-estimate

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!